Cbl & Associates Properties Inc
CBL NYSE Real Estate Investment Trusts Financials FY2015βFY2025
What Cbl & Associates Properties Inc does
No business description yet.
- Legal name
- CBL & ASSOCIATES PROPERTIES INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 3, 2026
- Accession Β· CIK
- 0001193125-26-087049
0000910612
Revenue and margins
Cbl & Associates Properties Inc had $578M of revenue in fiscal 2025, up 12.2% on the year before.
Net income and earnings per share
From fiscal 2015 to 2025, diluted EPS grew 32.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cbl & Associates Properties Inc returned $95.2M to shareholders in fiscal 2025. The diluted share count fell 0.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Cbl & Associates Properties Inc can carry it.
| Fiscal year end | FY20 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $61.8M | $44.7M | $34.2M | $40.8M | $42.3M |
| Debt incl. finance leases | $1.2B | $2.0B | $1.9B | $2.2B | $2.2B |
| Debt / equity | 2.2x | 5.4x | 5.6x | 6.8x | 5.8x |
| Total assets | $4.4B | $2.7B | $2.4B | $2.7B | $2.7B |
| Total liabilities | $3.9B | $2.3B | $2.1B | $2.4B | $2.4B |
| Shareholders' equity | $532M | $371M | $339M | $324M | $375M |
| Net debt (β = net cash) | $1.1B | $2.0B | $1.9B | $2.2B | $2.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 1 | β / 4 | β / 6 | 2 / 7 | 3 / 7 | 3 / 7 | β / 4 | 5 / 7 | 7 / 7 |
| Accruals ratio | β | β | β5.2% | β8.3% | β7.7% | β9.5% | β7.0% | β5.6% | β4.2% |
| Altman Z'' | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $1.0B | $927M | $859M | $769M | $576M | β | $535M | $516M | $578M |
| Operating income | $278M | $254M | $233M | β | β | β | β | β | β | β |
| Interest expense | $229M | $216M | $219M | $220M | $206M | $201M | β | $173M | $154M | $176M |
| Pretax income | β | β | $157M | β | β | β | β | β | β | β |
| Income tax | $2.9M | β$2.1M | β$1.9M | β$1.6M | $3.2M | $16.8M | β | $0.9M | $1.1M | $0.5M |
| Net income | $103M | $173M | $121M | β$78.6M | β$109M | β$295M | β | $6.5M | $59.0M | $136M |
| Net income to common | $58.5M | $128M | $76.0M | β$123M | β$154M | β$332M | β | $5.4M | $57.8M | $134M |
| Diluted EPS | $0.34 | $0.75 | $0.44 | β$0.72 | β$0.89 | β$1.75 | β | $0.17 | $1.87 | $4.34 |
| Diluted shares | β | β | 0.00B | 0.00B | 0.00B | 0.00B | β | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | β | β | $430M | $377M | $273M | $133M | β | $184M | $202M | $250M |
| Depreciation and amortization | $299M | $293M | $299M | $285M | $258M | $215M | β | $191M | $141M | $165M |
| Stock-based compensation | $4.3M | $4.7M | $5.8M | $5.4M | $4.8M | $5.8M | β | $13.0M | $14.9M | $16.7M |
| Share buybacks | β | β | β | β | β | β | β | $1.1M | $36.5M | $18.1M |
| Dividends paid | β | β | $181M | $138M | $26.0M | β | β | $118M | $50.4M | $77.1M |
| Dividends and buybacks | β | β | $181M | $138M | $26.0M | β | β | $119M | $86.8M | $95.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $36.9M | $19.0M | $32.6M | $25.1M | $32.8M | $61.8M | $44.7M | $34.2M | $40.8M | $42.3M |
| Total debt | $4.7B | $4.5B | $4.2B | $4.0B | $3.5B | $1.2B | $2.0B | $1.9B | $2.2B | $2.2B |
| Total assets | $6.5B | $6.1B | $5.7B | $5.3B | $4.6B | $4.4B | $2.7B | $2.4B | $2.7B | $2.7B |
| Total liabilities | $5.1B | $4.7B | $4.5B | $4.3B | $3.8B | $3.9B | $2.3B | $2.1B | $2.4B | $2.4B |
| Shareholders' equity | $1.3B | $1.2B | $1.1B | $964M | $806M | $532M | $371M | $339M | $324M | $375M |
| Margins | ||||||||||
| Operating margin | 26.3% | 24.7% | 25.1% | β | β | β | β | β | β | β |
| EBITDA margin | 54.7% | 53.1% | 57.3% | β | β | β | β | β | β | β |
| Net margin | 9.8% | 16.8% | 13.0% | β9.2% | β14.2% | β51.2% | β | 1.2% | 11.4% | 23.5% |
| Returns | ||||||||||
| Return on capital | 3.7% | 3.5% | 4.4% | β | β | β | β | β | β | β |
| Return on equity | 8.0% | 13.8% | 10.2% | β7.5% | β12.3% | β44.1% | β | 1.8% | 17.8% | 38.9% |
| Return on assets | 1.6% | 2.7% | 2.0% | β1.4% | β2.2% | β6.5% | β | 0.3% | 2.3% | 5.0% |
| Return on tangible equity | 4.6% | 10.4% | 6.7% | β12.8% | β19.1% | β62.5% | β | 1.6% | 17.9% | 35.7% |
| Growth | ||||||||||
| Revenue growth | β | β2.5% | β9.8% | β7.4% | β10.5% | β25.1% | β | β | β3.7% | 12.2% |
| Net income growth | β | 67.2% | β30.0% | β165.0% | β | β | β | β | 800.9% | 130.6% |
| EPS growth | β | 120.6% | β41.3% | β263.6% | β | β | β | β | 1,000.0% | 132.1% |
| Share count change | β | β | β | 0.8% | 0.5% | 9.7% | β | β | β1.1% | β0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 8.1x | 8.1x | 7.9x | β | β | β | β | β | β | β |
| Debt / equity | 3.7x | 3.6x | 3.7x | 4.2x | 4.4x | 2.2x | 5.4x | 5.6x | 6.8x | 5.8x |
| Interest coverage | 1.2x | 1.2x | 1.1x | β | β | β | β | β | β | β |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.4% | 0.5% | 0.6% | 0.6% | 0.6% | 1.0% | β | 2.4% | 2.9% | 2.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | 2.0 | 3.0 | 3.0 | β | β | 5.0 | 7.0 |
| Accruals ratio | β | β | β5.2% | β8.3% | β7.7% | β9.5% | β | β7.0% | β5.6% | β4.2% |
Source: SEC EDGAR XBRL filings (CIK 0000910612). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.